Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects

Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects

Apolipoprotein (apo) C-III and apoE play a central role in controlling the plasma metabolism of triglyceride-rich lipoproteins (TRL). We have investigated the plasma kinetics of total, very low density lipoprotein (VLDL) and high density lipoprotein (HDL) apoC-III and apoE in normolipidemic (NL) (n...

Full description

Bibliographic Details
Main Authors:	Rami Batal, Michel Tremblay, P. Hugh R. Barrett, Hélène Jacques, Alexandre Fredenrich, Orval Mamer, Jean Davignon, Jeffrey S. Cohn
Format:	Article
Language:	English
Published:	Elsevier 2000-05-01
Series:	Journal of Lipid Research
Subjects:	triglyceride cholesterol atherosclerosis type III hyperlipoproteinemia remnants stable isotope
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520323798

Similar Items

Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects
by: Jeffrey S. Cohn, et al.
Published: (2002-10-01)

Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans
by: Jeffrey S. Cohn, et al.
Published: (2003-10-01)

Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions
by: A Fredenrich, et al.
Published: (1997-07-01)

Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state
by: Caroline Marcoux, et al.
Published: (2000-09-01)

Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia
by: Jeffrey S. Cohn, et al.
Published: (2002-09-01)

Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE
by: Jeffrey S. Cohn, et al.
Published: (2004-08-01)

Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients
by: Klaus G. Parhofer, et al.
Published: (2003-06-01)

A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis
by: Pinilla-Monsalve GD, et al.
Published: (2020-03-01)

Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL
by: Stewart C. Whitman, et al.
Published: (1998-05-01)

Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI–APOE cluster
by: D.M. Waterworth, et al.
Published: (2000-07-01)

Identification of Rev-erbα as a physiological repressor of apoC-III gene transcription1
by: Eric Raspé, et al.
Published: (2002-12-01)

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
by: Jan Borén, et al.
Published: (2020-07-01)

Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients
by: Caroline Marcoux, et al.
Published: (1999-04-01)

Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results1
by: Xiaohong Yang, et al.
Published: (2016-04-01)

ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression
by: Gery Gerritsen, et al.
Published: (2005-07-01)

ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
by: Bastian Ramms, et al.
Published: (2019-08-01)

Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia
by: Hannia Campos, et al.
Published: (2001-08-01)

Oxidized cholesterol in the diet is a source of oxidized lipoproteins in human serum
by: Ilona Staprans, et al.
Published: (2003-04-01)

Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins
by: Jeremy D. Furtado, et al.
Published: (2012-04-01)

Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma
by: Minh N. Nguyen, et al.
Published: (2006-06-01)

Lipolytic remnants of human VLDL produced in vitro: effect of HDL levels in the lipolysis mixtures on the apoCs to apoE ratio and metabolic properties of VLDL core remnants
by: Byung Hong Chung, et al.
Published: (2000-02-01)

ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency*
by: Gery Gerritsen, et al.
Published: (2008-05-01)

Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA1
by: Naohiko Sakai, et al.
Published: (2003-06-01)

apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL[S]
by: Panagiotis Fotakis, et al.
Published: (2014-07-01)

ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
by: Katherine Olin-Lewis, et al.
Published: (2002-11-01)

Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL
by: Jimmy F.P. Berbée, et al.
Published: (2005-02-01)

The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient “apoB-48-only” and “apoB-100-only” mice
by: Helén L. Dichek, et al.
Published: (2004-03-01)

Sex differences in HDL ApoC-III in American Indian youth
by: Blackett Piers R, et al.
Published: (2012-08-01)

WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects[S]
by: Yannick Cyr, et al.
Published: (2016-06-01)

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies
by: Hayato Tada, et al.
Published: (2018-11-01)

The relationship of nutritional practices and related demographic variables
by: Scott, Elaine Marion
Published: (2010)

Ghrelin Levels in Male Patients with Hyperlipoproteinemia I, II versus Type 2 Diabetes Mellitus.
by: Salma A. Abbas, et al.
Published: (2014-07-01)

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
by: Klaus G. Parhofer
Published: (2015-10-01)

Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus1
by: Gissette Reyes-Soffer, et al.
Published: (2009-09-01)

Preferential clearance of apoB-48-containing lipoproteins after heparin-induced lipolysis is modulated by lipoprotein lipase activity1
by: André P. van Beek, et al.
Published: (1998-02-01)

Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men
by: Charles Couillard, et al.
Published: (2003-05-01)

Assessment of the Relationship between Hyperlipoproteinemias and Biliary Lithiasis
by: Dan BANUT, et al.
Published: (2009-01-01)

Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia
by: Frank G. Schaap, et al.
Published: (2006-10-01)

Prognostic utility of triglyceride-rich lipoprotein-related markers in patients with coronary artery disease
by: Ye-Xuan Cao, et al.
Published: (2020-09-01)

Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia
by: Yunpeng Guan, et al.
Published: (2021-04-01)